July 24, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJuly 09, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJuly 24, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
The automated and closed cell therapy processing systems market size is calculated at $1.74 bn in 2025 is to hit $8.86 bn by 2034. The automated and closed cell therapy market sees key advancements: Cellular Origins partnered with Fresenius Kabi (Oct 2024) for robotic manufacturing; Multiply Labs collaborated with Stanford Medicine (Apr 2024) on au...
April 21, 2026
According to market projections, the CRISPR technology sector is expected to grow from USD 5.72 billion in 2024 to USD 26.22 billion by 2034, reflecting a CAGR of 16.54%. In 2024, North America led the global CRISPR technology market, while Asia-Pacific is set for the fastest growth. Products dominated, but services are expected to grow the quickes...
April 21, 2026
Market insights predict the global animal genetics industry will increase from USD 6.51 billion in 2024 to USD 12.11 billion by 2034, achieving a CAGR of 6.4%. In 2024, North America led the animal genetics market with a 32% share, while Asia-Pacific is set for the fastest growth. Cattle dominated by animal type, but companion animals will grow the...
April 21, 2026
Market insights predicts the genetic material market is set for strong growth from 2025 to 2034, driven by gene therapies, personalized medicine, and biopharma research. North America led in 2024, while Asia Pacific will grow fastest. DNA dominated, but RNA is rising. Genomics led in 2024, with drug discovery and pharma seeing major expansion....
April 21, 2026
Based on market forecasts, the plasmid purification sector will expand from USD 1.95 billion in 2024 to USD 5.88 billion by 2034, experiencing a CAGR of 11.64%. In 2024, North America led the plasmid purification market with a 41% share, while Asia Pacific is set for the fastest growth. Products dominated, but services will expand rapidly. Molecula...
April 21, 2026
Based on market forecasts, the genome sequencing sector will expand from USD 22.63 billion in 2024 to USD 101.93 billion by 2034, experiencing a CAGR of 16.24%. In 2024, North America led the genome sequencing market, with consumables and next-generation sequencing as key segments. The clinical and academic research sectors dominated. Asia Pacific ...
April 21, 2026
Biospecimen Procurement Market (By Type: Oncological Studies, Non-Oncological Studies; By Region: North America, Asia Pacific, Europe, Latin America, Middle East and Africa) Global Analysis, Size, Trends, Leading Companies, Regional Outlook and Forecast 2026 to 2035....
April 21, 2026
Market insights predict the global single nucleotide polymorphism (SNP) genotyping industry will increase from USD 6.48 billion in 2024 to USD 19.48 billion by 2034, achieving a CAGR of 11.7%. The single nucleotide polymorphism (SNP) genotyping market is expanding due to rising genetic disorders as well as increasing developments in precision medic...
April 21, 2026
Based on market forecasts, the global whole genome sequencing market, projected at USD 2.15 billion in 2024, is expected to reach USD 15.96 billion by 2034, growing at a CAGR of 22.2% over the forecast period. The market is growing due to increasing demand for precision medicine and early disease detection. Failing costs and faster sequencing techn...
April 21, 2026
Projections indicate that, the global viral vector manufacturing market will increase from USD 1.82 billion in 2025 to USD 12.91 billion by 2035, experiencing a CAGR of 21.64% over the next 10 years. The market is growing due to rising demand for gene and cell therapies, particularly for treating cancer and rare genetic disorders. Increased investm...
+1 804 441 9344
+65 3106 5601 or +91 87933 22019
